These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 32055820)

  • 21. Comparison of the disease activity score using the erythrocyte sedimentation rate and C-reactive protein levels in Koreans with rheumatoid arthritis.
    Son KM; Kim SY; Lee SH; Yang CM; Seo YI; Kim HA
    Int J Rheum Dis; 2016 Dec; 19(12):1278-1283. PubMed ID: 26200604
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Doppler ultrasound impacts response to intravenous tocilizumab in rheumatoid arthritis patients.
    Morris NT; Brook J; Ben-Artzi A; Martin W; Kermani TA; Avedikian-Tatosyan L; Karpouzas G; Nagam H; Navarro G; Choi S; Taylor MB; Elashoff D; Kaeley GS; Ranganath VK
    Clin Rheumatol; 2021 Dec; 40(12):5055-5065. PubMed ID: 34269927
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inadequate Dietary Nutrient Intake in Patients With Rheumatoid Arthritis in Southwestern Sweden: A Cross-Sectional Study.
    Turesson Wadell A; Bärebring L; Hulander E; Gjertsson I; Lindqvist HM; Winkvist A
    Front Nutr; 2022; 9():915064. PubMed ID: 35799579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of pateclizumab (anti-lymphotoxin-α) compared to adalimumab in rheumatoid arthritis: a head-to-head phase 2 randomized controlled study (The ALTARA Study).
    Kennedy WP; Simon JA; Offutt C; Horn P; Herman A; Townsend MJ; Tang MT; Grogan JL; Hsieh F; Davis JC
    Arthritis Res Ther; 2014 Oct; 16(5):467. PubMed ID: 25359150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thresholds for the 28-joint disease activity score (DAS28) using C-reactive protein are lower compared to DAS28 using erythrocyte sedimentation rate in early rheumatoid arthritis.
    Kuriya B; Schieir O; Lin D; Xiong J; Pope J; Boire G; Haraoui B; Thorne JC; Tin D; Hitchon C; Jamal S; Keystone E; Bykerk VP;
    Clin Exp Rheumatol; 2017; 35(5):799-803. PubMed ID: 28339365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Infliximab equivalently suppresses oxidative stress compared to tocilizumab among well-controlled patients with rheumatoid arthritis.
    Kizaki K; Yamashita F; Hayashi T; Funakoshi N
    Int J Rheum Dis; 2018 Oct; 21(10):1815-1821. PubMed ID: 27778459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting ultrasound remission in early rheumatoid arthritis: the results of the TaSER study, a randomised clinical trial.
    Dale J; Stirling A; Zhang R; Purves D; Foley J; Sambrook M; Conaghan PG; van der Heijde D; McConnachie A; McInnes IB; Porter D
    Ann Rheum Dis; 2016 Jun; 75(6):1043-50. PubMed ID: 27026689
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Semi-quantitative analysis of
    Ravikanth R; Singh JK
    World J Nucl Med; 2020; 19(4):347-352. PubMed ID: 33623503
    [No Abstract]   [Full Text] [Related]  

  • 29. Remission in rheumatoid arthritis by different criteria does not converge over the inflammatory markers.
    Chandrashekara S; Priyanka BU
    Int J Rheum Dis; 2013 Jun; 16(3):291-6. PubMed ID: 23981750
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Sanhuangyilong decoction plus methotrexate on tumor necrosis factor alpha and interferon gamma in serum and synovial fluid in rheumatoid arthritis patients with symptom pattern of damp heat obstruction.
    Liu D; Yan J; Yun M; Yang M; Luo Y; Zhang J; Guo M; Yang M; Yuan W; Zou W; Li H; Hu Y
    J Tradit Chin Med; 2016 Oct; 36(5):625-33. PubMed ID: 29933531
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discontinuation of adalimumab after attaining disease activity score 28-erythrocyte sedimentation rate remission in patients with rheumatoid arthritis (HONOR study): an observational study.
    Hirata S; Saito K; Kubo S; Fukuyo S; Mizuno Y; Iwata S; Nawata M; Sawamukai N; Nakano K; Yamaoka K; Tanaka Y
    Arthritis Res Ther; 2013 Sep; 15(5):R135. PubMed ID: 24286472
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determining Pathways to Improvements in Fatigue in Rheumatoid Arthritis: Results From the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis.
    Druce KL; Jones GT; Macfarlane GJ; Basu N
    Arthritis Rheumatol; 2015 Sep; 67(9):2303-10. PubMed ID: 26108189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis: the treatment of Early Aggressive Rheumatoid Arthritis Trial.
    Moreland LW; O'Dell JR; Paulus HE; Curtis JR; Bathon JM; St Clair EW; Bridges SL; Zhang J; McVie T; Howard G; van der Heijde D; Cofield SS;
    Arthritis Rheum; 2012 Sep; 64(9):2824-35. PubMed ID: 22508468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between neutrophil-lymphocyte, platelet-lymphocyte ratio and disease activity in rheumatoid arthritis treated with rituximab.
    Sargin G; Senturk T; Yavasoglu I; Kose R
    Int J Rheum Dis; 2018 Dec; 21(12):2122-2127. PubMed ID: 30338636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Down-titration and discontinuation strategies of tumor necrosis factor-blocking agents for rheumatoid arthritis in patients with low disease activity.
    van Herwaarden N; den Broeder AA; Jacobs W; van der Maas A; Bijlsma JW; van Vollenhoven RF; van den Bemt BJ
    Cochrane Database Syst Rev; 2014 Sep; (9):CD010455. PubMed ID: 25264908
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Positive association between serum thymic stromal lymphopoietin and anti-citrullinated peptide antibodies in patients with rheumatoid arthritis.
    Koyama K; Ohba T; Haro H; Nakao A
    Clin Exp Immunol; 2015 Aug; 181(2):239-43. PubMed ID: 25817699
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The multi-biomarker disease activity score tracks response to rituximab treatment in rheumatoid arthritis patients: a post hoc analysis of three cohort studies.
    Roodenrijs NMT; de Hair MJH; Wheater G; Elshahaly M; Tekstra J; Teng YKO; Lafeber FPJG; Hwang CC; Liu X; Sasso EH; van Laar JM
    Arthritis Res Ther; 2018 Nov; 20(1):256. PubMed ID: 30458871
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Soluble urokinase plasminogen activator receptor (suPAR) in the assessment of inflammatory activity of rheumatoid arthritis patients in remission.
    Toldi G; Bekő G; Kádár G; Mácsai E; Kovács L; Vásárhelyi B; Balog A
    Clin Chem Lab Med; 2013 Feb; 51(2):327-32. PubMed ID: 22718576
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ultrasound evaluation of the effects of leukocytapheresis on rheumatoid arthritis.
    Yoshida S; Takeuchi T; Maeda Y; Kimura Y; Hata K; Hiramatsu Y; Shoda T; Makino S; Hanafusa T; Shibahara N
    Ther Apher Dial; 2014 Oct; 18(5):509-14. PubMed ID: 24251814
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intake frequency of vegetables or seafoods negatively correlates with disease activity of rheumatoid arthritis.
    Murakami I; Murakami K; Hashimoto M; Tanaka M; Ito H; Fujii T; Torii M; Ikeda K; Kuwabara A; Tanaka K; Yoshida A; Akizuki S; Nakashima R; Yoshifuji H; Ohmura K; Usui T; Morita S; Mimori T
    PLoS One; 2020; 15(2):e0228852. PubMed ID: 32053642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.